{"entity":{"type":"insider","cik":"0001765253","url":"/insider/0001765253","json_url":"/insider/0001765253.json","name":"Versant Vantage I, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":104,"n_filings":29,"first":"2019-10-07","last":"2025-09-23","span_basis":"filed_date"},"name_variants":[{"name":"Versant Vantage I, L.P.","source":"filing","n_filings":29,"first_seen":"2019-10-07","last_seen":"2025-09-23"}],"transactions":[{"id":5025160,"accession":"0001193125-25-213445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-213445","line_url":"/filing/0001193125-25-213445#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2370533.0,"shares_display":"2,370,533","price_per_share":1.4014,"price_display":"1.40","price_state":"stated","total_value":3322064.9462,"total_display":"3,322,064.95","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-23","scope":"insider"},{"id":5025155,"accession":"0001193125-25-213445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-213445","line_url":"/filing/0001193125-25-213445#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":532870.0,"shares_display":"532,870","price_per_share":1.4014,"price_display":"1.40","price_state":"stated","total_value":746764.018,"total_display":"746,764.02","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-23","scope":"insider"},{"id":4990228,"accession":"0001193125-25-207677","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366111.0,"shares_display":"366,111","price_per_share":1.4418,"price_display":"1.44","price_state":"stated","total_value":527858.8398,"total_display":"527,858.84","shares_owned_after":2370533.0,"shares_owned_after_display":"2,370,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-18","scope":"insider"},{"id":4990222,"accession":"0001193125-25-207677","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228791.0,"shares_display":"228,791","price_per_share":1.4418,"price_display":"1.44","price_state":"stated","total_value":329870.8638,"total_display":"329,870.86","shares_owned_after":532870.0,"shares_owned_after_display":"532,870","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-18","scope":"insider"},{"id":4990217,"accession":"0001193125-25-207677","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":362806.0,"shares_display":"362,806","price_per_share":1.4892,"price_display":"1.49","price_state":"stated","total_value":540290.6952,"total_display":"540,290.70","shares_owned_after":2736644.0,"shares_owned_after_display":"2,736,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4990211,"accession":"0001193125-25-207677","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226726.0,"shares_display":"226,726","price_per_share":1.4892,"price_display":"1.49","price_state":"stated","total_value":337640.3592,"total_display":"337,640.36","shares_owned_after":761661.0,"shares_owned_after_display":"761,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4990207,"accession":"0001193125-25-207677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":307707.0,"shares_display":"307,707","price_per_share":1.5332,"price_display":"1.53","price_state":"stated","total_value":471776.3724,"total_display":"471,776.37","shares_owned_after":3099450.0,"shares_owned_after_display":"3,099,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4990202,"accession":"0001193125-25-207677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192293.0,"shares_display":"192,293","price_per_share":1.5332,"price_display":"1.53","price_state":"stated","total_value":294823.6276,"total_display":"294,823.63","shares_owned_after":988387.0,"shares_owned_after_display":"988,387","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":3112863,"accession":"0000950170-24-119051","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000950170-24-119051","line_url":"/filing/0000950170-24-119051#line-13","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52305.0,"shares_display":"52,305","price_per_share":9.0815,"price_display":"9.08","price_state":"stated","total_value":475007.8575,"total_display":"475,007.86","shares_owned_after":1589053.0,"shares_owned_after_display":"1,589,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-30","scope":"insider"},{"id":3112859,"accession":"0000950170-24-119051","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950170-24-119051","line_url":"/filing/0000950170-24-119051#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15600.0,"shares_display":"15,600","price_per_share":9.4098,"price_display":"9.41","price_state":"stated","total_value":146792.88,"total_display":"146,792.88","shares_owned_after":1573453.0,"shares_owned_after_display":"1,573,453","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-30","scope":"insider"},{"id":3112856,"accession":"0000950170-24-119051","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950170-24-119051","line_url":"/filing/0000950170-24-119051#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89990.0,"shares_display":"89,990","price_per_share":9.6593,"price_display":"9.66","price_state":"stated","total_value":869240.407,"total_display":"869,240.41","shares_owned_after":2007948.0,"shares_owned_after_display":"2,007,948","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider"},{"id":2083039,"accession":"0000950170-24-109112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-109112","line_url":"/filing/0000950170-24-109112#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1132566.0,"shares_display":"1,132,566","price_per_share":6.5296,"price_display":"6.53","price_state":"stated","total_value":7395202.9536,"total_display":"7,395,202.95","shares_owned_after":5099336.0,"shares_owned_after_display":"5,099,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider"},{"id":2897808,"accession":"0000950170-24-106532","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-106532","line_url":"/filing/0000950170-24-106532#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9269.0,"shares_display":"9,269","price_per_share":6.1603,"price_display":"6.16","price_state":"stated","total_value":57099.8207,"total_display":"57,099.82","shares_owned_after":6231902.0,"shares_owned_after_display":"6,231,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-13","scope":"insider"},{"id":2897804,"accession":"0000950170-24-106532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-106532","line_url":"/filing/0000950170-24-106532#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16047.0,"shares_display":"16,047","price_per_share":6.0017,"price_display":"6.00","price_state":"stated","total_value":96309.2799,"total_display":"96,309.28","shares_owned_after":6241171.0,"shares_owned_after_display":"6,241,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-13","scope":"insider"},{"id":2897797,"accession":"0000950170-24-106532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-106532","line_url":"/filing/0000950170-24-106532#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541897.0,"shares_display":"541,897","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3251382.0,"total_display":"3,251,382.00","shares_owned_after":6257218.0,"shares_owned_after_display":"6,257,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider"},{"id":2389239,"accession":"0000950170-24-102354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-102354","line_url":"/filing/0000950170-24-102354#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":221600.0,"shares_display":"221,600","price_per_share":6.3202,"price_display":"6.32","price_state":"stated","total_value":1400556.32,"total_display":"1,400,556.32","shares_owned_after":3726341.0,"shares_owned_after_display":"3,726,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-30","scope":"insider"},{"id":6803913,"accession":"0000899243-22-021350","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-021350","line_url":"/filing/0000899243-22-021350#line-5","is_derivative":false,"issuer_cik":"0001765253","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001765253","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":438795.0,"shares_display":"438,795","price_per_share":12.2517,"price_display":"12.25","price_state":"stated","total_value":5375984.7015,"total_display":"5,375,984.70","shares_owned_after":1464875.0,"shares_owned_after_display":"1,464,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6803909,"accession":"0000899243-22-021350","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-021350","line_url":"/filing/0000899243-22-021350#line-4","is_derivative":false,"issuer_cik":"0001765253","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001765253","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":12.2517,"price_display":"12.25","price_state":"stated","total_value":3062925.0,"total_display":"3,062,925.00","shares_owned_after":2344451.0,"shares_owned_after_display":"2,344,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6803907,"accession":"0000899243-22-021350","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-021350","line_url":"/filing/0000899243-22-021350#line-3","is_derivative":false,"issuer_cik":"0001765253","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001765253","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33395.0,"shares_display":"33,395","price_per_share":12.2517,"price_display":"12.25","price_state":"stated","total_value":409145.5215,"total_display":"409,145.52","shares_owned_after":111484.0,"shares_owned_after_display":"111,484","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6803903,"accession":"0000899243-22-021350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021350","line_url":"/filing/0000899243-22-021350#line-2","is_derivative":false,"issuer_cik":"0001765253","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001765253","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14611.0,"shares_display":"14,611","price_per_share":12.2517,"price_display":"12.25","price_state":"stated","total_value":179009.5887,"total_display":"179,009.59","shares_owned_after":48776.0,"shares_owned_after_display":"48,776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6803898,"accession":"0000899243-22-021350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021350","line_url":"/filing/0000899243-22-021350#line-1","is_derivative":false,"issuer_cik":"0001765253","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001765253","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13199.0,"shares_display":"13,199","price_per_share":12.2517,"price_display":"12.25","price_state":"stated","total_value":161710.1883,"total_display":"161,710.19","shares_owned_after":44065.0,"shares_owned_after_display":"44,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":5328599,"accession":"0000899243-21-040777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-040777","line_url":"/filing/0000899243-21-040777#line-4","is_derivative":false,"issuer_cik":"0001456589","issuer_name":"Oyster Point Pharma, Inc.","issuer_ticker":"OYST","issuer_name_source":null,"issuer_url":"/issuer/0001456589","owner_cik":null,"owner_name":"Versant Vantage I GP-GP, LLC; Versant Side Fund IV, L.P.; Versant Ventures IV, LLC; Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Ventures VI GP, L.P.; Versant Venture Capital IV, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":303614.0,"shares_display":"303,614","price_per_share":14.6327,"price_display":"14.63","price_state":"stated","total_value":4442692.5778,"total_display":"4,442,692.58","shares_owned_after":1057976.0,"shares_owned_after_display":"1,057,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-20","scope":"insider"},{"id":5328596,"accession":"0000899243-21-040777","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-040777","line_url":"/filing/0000899243-21-040777#line-3","is_derivative":false,"issuer_cik":"0001456589","issuer_name":"Oyster Point Pharma, Inc.","issuer_ticker":"OYST","issuer_name_source":null,"issuer_url":"/issuer/0001456589","owner_cik":null,"owner_name":"Versant Vantage I GP-GP, LLC; Versant Side Fund IV, L.P.; Versant Ventures IV, LLC; Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Ventures VI GP, L.P.; Versant Venture Capital IV, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242943.0,"shares_display":"242,943","price_per_share":15.0939,"price_display":"15.09","price_state":"stated","total_value":3666957.3477,"total_display":"3,666,957.35","shares_owned_after":815033.0,"shares_owned_after_display":"815,033","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-20","scope":"insider"},{"id":5328590,"accession":"0000899243-21-040777","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-040777","line_url":"/filing/0000899243-21-040777#line-2","is_derivative":false,"issuer_cik":"0001456589","issuer_name":"Oyster Point Pharma, Inc.","issuer_ticker":"OYST","issuer_name_source":null,"issuer_url":"/issuer/0001456589","owner_cik":null,"owner_name":"Versant Vantage I GP-GP, LLC; Versant Side Fund IV, L.P.; Versant Ventures IV, LLC; Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Ventures VI GP, L.P.; Versant Venture Capital IV, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":14.6327,"price_display":"14.63","price_state":"stated","total_value":27977.7224,"total_display":"27,977.72","shares_owned_after":6518.0,"shares_owned_after_display":"6,518","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-20","scope":"insider"},{"id":5328586,"accession":"0000899243-21-040777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-040777","line_url":"/filing/0000899243-21-040777#line-1","is_derivative":false,"issuer_cik":"0001456589","issuer_name":"Oyster Point Pharma, Inc.","issuer_ticker":"OYST","issuer_name_source":null,"issuer_url":"/issuer/0001456589","owner_cik":null,"owner_name":"Versant Vantage I GP-GP, LLC; Versant Side Fund IV, L.P.; Versant Ventures IV, LLC; Versant Vantage I, L.P.; Versant Vantage I GP, L.P.; Versant Ventures VI GP, L.P.; Versant Venture Capital IV, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1531.0,"shares_display":"1,531","price_per_share":15.0939,"price_display":"15.09","price_state":"stated","total_value":23108.7609,"total_display":"23,108.76","shares_owned_after":4987.0,"shares_owned_after_display":"4,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-20","scope":"insider"},{"id":5237384,"accession":"0000899243-21-026766","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-026766","line_url":"/filing/0000899243-21-026766#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC; Versant Vantage I, L.P.; Versant Ventures VI GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":157895.0,"shares_display":"157,895","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":3000005.0,"total_display":"3,000,005.00","shares_owned_after":2097938.0,"shares_owned_after_display":"2,097,938","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":2169844,"accession":"0000899243-20-032389","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-032389","line_url":"/filing/0000899243-20-032389#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10193.0,"shares_display":"10,193","price_per_share":33.1286,"price_display":"33.13","price_state":"stated","total_value":337679.8198,"total_display":"337,679.82","shares_owned_after":874299.0,"shares_owned_after_display":"874,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-01","scope":"insider"},{"id":2169840,"accession":"0000899243-20-032389","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-20-032389","line_url":"/filing/0000899243-20-032389#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":34.1646,"price_display":"34.16","price_state":"stated","total_value":6832.92,"total_display":"6,832.92","shares_owned_after":874099.0,"shares_owned_after_display":"874,099","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-01","scope":"insider"},{"id":2858129,"accession":"0000899243-20-031918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031918","line_url":"/filing/0000899243-20-031918#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114854.0,"shares_display":"114,854","price_per_share":33.01,"price_display":"33.01","price_state":"stated","total_value":3791330.54,"total_display":"3,791,330.54","shares_owned_after":4818600.0,"shares_owned_after_display":"4,818,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2858125,"accession":"0000899243-20-031918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031918","line_url":"/filing/0000899243-20-031918#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15163.0,"shares_display":"15,163","price_per_share":33.01,"price_display":"33.01","price_state":"stated","total_value":500530.63,"total_display":"500,530.63","shares_owned_after":968954.0,"shares_owned_after_display":"968,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2385485,"accession":"0000899243-20-031771","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":473.0,"shares_display":"473","price_per_share":33.0938,"price_display":"33.09","price_state":"stated","total_value":15653.3674,"total_display":"15,653.37","shares_owned_after":4933454.0,"shares_owned_after_display":"4,933,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider"},{"id":2385481,"accession":"0000899243-20-031771","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63.0,"shares_display":"63","price_per_share":33.0938,"price_display":"33.09","price_state":"stated","total_value":2084.9094,"total_display":"2,084.91","shares_owned_after":984117.0,"shares_owned_after_display":"984,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider"},{"id":2385479,"accession":"0000899243-20-031771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3705.0,"shares_display":"3,705","price_per_share":33.0498,"price_display":"33.05","price_state":"stated","total_value":122449.509,"total_display":"122,449.51","shares_owned_after":4933927.0,"shares_owned_after_display":"4,933,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider"},{"id":2385475,"accession":"0000899243-20-031771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":489.0,"shares_display":"489","price_per_share":33.0498,"price_display":"33.05","price_state":"stated","total_value":16161.3522,"total_display":"16,161.35","shares_owned_after":984180.0,"shares_owned_after_display":"984,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider"},{"id":2288331,"accession":"0000899243-20-031322","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177.0,"shares_display":"177","price_per_share":33.0125,"price_display":"33.01","price_state":"stated","total_value":5843.2125,"total_display":"5,843.21","shares_owned_after":4937632.0,"shares_owned_after_display":"4,937,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2288328,"accession":"0000899243-20-031322","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":33.0125,"price_display":"33.01","price_state":"stated","total_value":759.2875,"total_display":"759.29","shares_owned_after":984669.0,"shares_owned_after_display":"984,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2288322,"accession":"0000899243-20-031322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2473.0,"shares_display":"2,473","price_per_share":33.3149,"price_display":"33.31","price_state":"stated","total_value":82387.7477,"total_display":"82,387.75","shares_owned_after":4939311.0,"shares_owned_after_display":"4,939,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2288317,"accession":"0000899243-20-031322","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":34.5309,"price_display":"34.53","price_state":"stated","total_value":51865.4118,"total_display":"51,865.41","shares_owned_after":4937809.0,"shares_owned_after_display":"4,937,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2288309,"accession":"0000899243-20-031322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":327.0,"shares_display":"327","price_per_share":33.3149,"price_display":"33.31","price_state":"stated","total_value":10893.9723,"total_display":"10,893.97","shares_owned_after":984890.0,"shares_owned_after_display":"984,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2288304,"accession":"0000899243-20-031322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":34.5309,"price_display":"34.53","price_state":"stated","total_value":6837.1182,"total_display":"6,837.12","shares_owned_after":984692.0,"shares_owned_after_display":"984,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2732972,"accession":"0000899243-20-031061","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-16","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9450.0,"shares_display":"9,450","price_per_share":34.3928,"price_display":"34.39","price_state":"stated","total_value":325011.96,"total_display":"325,011.96","shares_owned_after":4942137.0,"shares_owned_after_display":"4,942,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732969,"accession":"0000899243-20-031061","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-15","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3976.0,"shares_display":"3,976","price_per_share":33.4774,"price_display":"33.48","price_state":"stated","total_value":133106.1424,"total_display":"133,106.14","shares_owned_after":4951587.0,"shares_owned_after_display":"4,951,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732967,"accession":"0000899243-20-031061","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-14","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1248.0,"shares_display":"1,248","price_per_share":34.3928,"price_display":"34.39","price_state":"stated","total_value":42922.2144,"total_display":"42,922.21","shares_owned_after":985264.0,"shares_owned_after_display":"985,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732965,"accession":"0000899243-20-031061","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-13","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":524.0,"shares_display":"524","price_per_share":33.4774,"price_display":"33.48","price_state":"stated","total_value":17542.1576,"total_display":"17,542.16","shares_owned_after":986512.0,"shares_owned_after_display":"986,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732963,"accession":"0000899243-20-031061","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":353.0,"shares_display":"353","price_per_share":35.1488,"price_display":"35.15","price_state":"stated","total_value":12407.5264,"total_display":"12,407.53","shares_owned_after":4941784.0,"shares_owned_after_display":"4,941,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732957,"accession":"0000899243-20-031061","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":35.1488,"price_display":"35.15","price_state":"stated","total_value":1651.9936,"total_display":"1,651.99","shares_owned_after":985217.0,"shares_owned_after_display":"985,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2908054,"accession":"0000899243-20-030855","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-8","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9027.0,"shares_display":"9,027","price_per_share":34.9372,"price_display":"34.94","price_state":"stated","total_value":315378.1044,"total_display":"315,378.10","shares_owned_after":5646377.0,"shares_owned_after_display":"5,646,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908051,"accession":"0000899243-20-030855","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-7","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2119.0,"shares_display":"2,119","price_per_share":33.8596,"price_display":"33.86","price_state":"stated","total_value":71748.4924,"total_display":"71,748.49","shares_owned_after":5655404.0,"shares_owned_after_display":"5,655,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908048,"accession":"0000899243-20-030855","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1191.0,"shares_display":"1,191","price_per_share":34.9372,"price_display":"34.94","price_state":"stated","total_value":41610.2052,"total_display":"41,610.21","shares_owned_after":987036.0,"shares_owned_after_display":"987,036","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908045,"accession":"0000899243-20-030855","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":33.8596,"price_display":"33.86","price_state":"stated","total_value":9480.688,"total_display":"9,480.69","shares_owned_after":988227.0,"shares_owned_after_display":"988,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"}],"next_cursor":"2020-11-11|2908045","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840748","name":"LAVA Therapeutics NV","url":"/issuer/0001840748","role":"Ten percent owner","n_filings":2,"first_seen":"2025-09-18","last_seen":"2025-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Ten percent owner","n_filings":4,"first_seen":"2021-06-30","last_seen":"2024-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001701541","name":"Black Diamond Therapeutics, Inc.","url":"/issuer/0001701541","role":"Ten percent owner","n_filings":16,"first_seen":"2020-02-05","last_seen":"2024-08-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001808158","name":"Repare Therapeutics Inc.","url":"/issuer/0001808158","role":"Ten percent owner","n_filings":2,"first_seen":"2020-06-25","last_seen":"2022-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001720725","name":"Oyster Point Pharma, Inc.","url":"/issuer/0001720725","role":"Ten percent owner","n_filings":2,"first_seen":"2019-11-04","last_seen":"2021-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001799448","name":"Aligos Therapeutics, Inc.","url":"/issuer/0001799448","role":"Ten percent owner","n_filings":1,"first_seen":"2020-10-20","last_seen":"2020-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Ten percent owner","n_filings":1,"first_seen":"2020-03-03","last_seen":"2020-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Ten percent owner","n_filings":1,"first_seen":"2019-10-07","last_seen":"2019-10-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001765253","retrieved_at":"2026-08-21T04:45:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}